Welcome to LookChem.com Sign In|Join Free

CAS

  • or

123065-60-1

Post Buying Request

123065-60-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

123065-60-1 Usage

General Description

3,5-bis(hydroxylmethyl)benzoic acid, also known as trimellitic acid, is a chemical compound with the molecular formula C10H10O6. It is a white crystalline solid that is soluble in water and exhibits acidic properties. It is commonly used in the production of various polymers, such as polyesters and polyamides. 3,5-bis(hydroxylmethyl)benzoic acid is also utilized as a cross-linking agent in the synthesis of epoxy resins. Additionally, it is employed in the manufacturing of adhesives, coatings, and plasticizers. Its ability to manipulate the physical and chemical properties of polymers makes it a valuable compound in the field of materials science and industrial applications.

Check Digit Verification of cas no

The CAS Registry Mumber 123065-60-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,0,6 and 5 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 123065-60:
(8*1)+(7*2)+(6*3)+(5*0)+(4*6)+(3*5)+(2*6)+(1*0)=91
91 % 10 = 1
So 123065-60-1 is a valid CAS Registry Number.

123065-60-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-bis(hydroxylmethyl)benzoic acid

1.2 Other means of identification

Product number -
Other names 3,5-bis(hydroxymethyl)benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:123065-60-1 SDS

123065-60-1Downstream Products

123065-60-1Relevant articles and documents

Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents

Bian, Hongzhu,Dong, Xun,Fu, Rong,Li, Congcong,Liu, Chang,Shen, Zhengwu,Xu, Wei,Xu, Zhenye,Zhang, Jinghua,Zhao, Xiaozhen,Zou, Xiaosu

, (2021)

A series of dihydroartemisinin derivatives was synthesized, and their anti-proliferation activity against cancer cells was evaluated. Structure-activity relationship studies led to the discovery of dihydroartemisinin-bile acid conjugates that exhibit broa

New water-soluble polyanionic dendrimers - Phosphoric and 1,3,5-benzenetricarboxylic acid derivatives

Salamonczyk, Grzegorz M.

, p. 10209 - 10217,9 (2020/09/02)

Simple, very efficient, and having some aspects of generality, synthesis of water-soluble, polyanionic dendrimeric polyesters with different size, polarity, and flexibility is described. These macromolecular compounds consisting of phosphate or thiophosph

TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

-

Page 70, (2010/02/10)

The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 123065-60-1